
Xonetri-S 0.5gm/0.5gm Injection
Marketer
RSM Lifecare India Private Ltd
Salt Composition
Cefoperazone (0.5gm) + Sulbactam (0.5gm)
Overview Xonetri-S 0.5gm/0.5gm Injection
Combiflox-Dual 0.5g/0.5g injection combats bacterial infections by inhibiting microbial proliferation. Administered only by a healthcare provider, this dual-action medication requires adherence to the prescribed dosage schedule. Complete the full course, even with symptom improvement, to prevent treatment failure. Premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; escalating symptoms necessitate immediate medical attention. Seek immediate help for allergic reactions (rash, itching, swelling, dyspnea). Inform your physician of all concurrent medications, particularly if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing, avoid driving if experiencing somnolence or dizziness. Ensure adequate rest, nutrition, and hydration for optimal recovery. Monitoring may include laboratory tests to assess therapeutic response.
Primary Ingredients of Xonetri-S 0.5gm/0.5gm Injection
There is no text provided to rephrase.
Uses of Xonetri-S 0.5gm/0.5gm Injection
Combating Bacterial Infections
Major Benefits of Xonetri-S 0.5gm/0.5gm Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
Common Side effects of Xonetri-S 0.5gm/0.5gm Injection:
- Decreased white blood cell count (neutrophils)
- Decreased white blood cell count (lymphocytes)
- Decreased hemoglobin
- Decreased hematocrit level
- Low blood platelets
- Coagulation disorder
- Increased white blood cell count (eosinophils)
- Diarrhea
- Nausea
- Increased alanine aminotransferase
- Increased aspartate aminotransferase
- Increased alkaline phosphatase level in blood
- Vomiting
- Increased bilirubin in the blood
How to use Xonetri-S 0.5gm/0.5gm Injection:
Administering this medication will be done by your physician or their designated nurse; self-medication is strictly prohibited.
How Xonetri-S 0.5gm/0.5gm Injection works:
Xonetri-S 0.5gm/0.5gm Injection combines Cefoperazone, a bacterial growth inhibitor, with Sulbactam, a beta-lactamase inhibitor. Cefoperazone's mechanism involves disrupting bacterial cell wall synthesis, essential for bacterial viability. Sulbactam's role is to counteract bacterial resistance, thereby improving Cefoperazone's effectiveness.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Xonetri-S 0.5gm/0.5gm Injection and alcohol may result in adverse effects including facial flushing, tachycardia, nausea, thirst, chest discomfort, and hypotension (a disulfiram-like reaction).
PregnancySAFE IF PRESCRIBED
The injectable medication Xonetri-S 0.5gm/0.5gm is typically deemed safe for use in pregnancy. Preclinical trials using animal models have revealed minimal or no harmful effects on fetal development; however, data from human clinical trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable formulation Xonetri-S (0.5gm/0.5gm) poses no known breastfeeding risk. Research in humans indicates negligible transfer to breast milk, posing no apparent danger to infants.
DrivingCONSULT YOUR DOCTOR
The impact of Xonetri-S 0.5gm/0.5gm Injection on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Xonetri-S 0.5gm/0.5gm Injection to individuals with renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding the administration of Xonetri-S 0.5gm/0.5gm Injection to individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Xonetri-S 0.5gm/0.5gm Injection :
Should you forget a dose of Xonetri-S 0.5gm/0.5gm Injection, seek medical advice.
Facts to Know About Xonetri-S 0.5gm/0.5gm Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
